Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electromotive magnesium sulphate administration for spastic gastrocnemius muscle in stroke patients
PACTR202011752304906Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of magnesium sulfate in stroke and Muscle spasm, sponsored by Cairo University. Primary endpoints: Spasticity of calf muscle and Electromyograph. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
strokeMuscle spasm
Beyond the preview
Go deeper on PACTR202011752304906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011752304906.